lentinan has been researched along with oxonic acid in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiba, Y; Aoki, D; Hibi, T; Ishii, H; Kato, S; Mukai, M; Naito, K; Takada, Y; Watanabe, C | 1 |
| Atomi, Y; Kusano, M; Mitsumori, N; Nakajima, M; Nimura, H; Suzuki, S; Tokunaga, A; Tsukagoshi, S; Yoshiyuki, T | 1 |
| Hayashi, T; Iijima, S; Kato, T; Kikkawa, N; Kimura, Y; Kurokawa, E; Matsuura, N; Naoi, Y; Tanigawa, T; Tsujie, M; Yamamoto, H | 1 |
| Andou, K; Hibi, T; Kurosawa, Y; Nagahashi, S; Nishiwaki, M; Okuda, K; Sugihara, T; Suzuki, H; Terada, S | 1 |
| Fukushima, M; Mushiake, H; Nukatsuka, M; Shimao, K; Tahara, H; Tsunoda, T | 1 |
| Hamuro, J | 1 |
| Kashimura, H; Kashiwagi, H; Mitsumori, N; Nimura, H; Takahashi, N; Takayama, S; Yanaga, K | 1 |
| Hirose, N; Kawano, T; Matsusaki, K; Minamisono, Y; Miura, O; Morita, M; Nagasaki, S; Okamoto, F; Okazaki, Y; Toda, T; Yamada, T | 1 |
| Oka, M; Yoshino, S | 1 |
| Dan, N; Fukuoka, T; Hirakawa, K; Hori, T; Ikehara, T; Nishino, H; Takatsuka, S; Tendou, M; Tezuka, K | 1 |
| Hazama, S; Nakazawa, S; Suga, T; Watanabe, S; Yagi, M; Yoshino, S | 1 |
| Kinoshita, K; Kondo, K; Watanabe, K | 1 |
| Matsunaga, N; Nakagawa, Y; Noda, S; Yanagawa, K | 1 |
| Akazawa, N; Imai, A; Iwaki, H; Kikuchi, H; Minato, M; Taguchi, K | 1 |
| Harada, K; Itashiki, Y; Takenawa, T; Ueyama, Y | 1 |
| Dan, N; Fukuoka, T; Hirakawa, K; Hori, T; Ikehara, T; Nishino, H; Takatsuka, S; Tendo, M; Tezuka, K | 1 |
| Inoue, K; Kawaguchi, Y; Kwon, AH; Michiura, T; Nakai, K; Nakane, Y; Ozaki, T; Takada, H; Ueyama, Y; Yamada, M | 1 |
| Egawa, Y; Futami, K; Higashi, D; Hirano, K; Ishibashi, Y; Koga, M; Maekawa, T; Mikami, K; Sasaki, T; Seki, K; Sudo, M | 1 |
| Kondo, J; Nagashima, Y; Nakamura, M; Nisimura, T; Okada, T; Sakata, K; Setoguchi, M; Yoshino, S | 1 |
| Aono, T; Deguchi, K; Deguchi, T; Endo, S; Fujitani, K; Fukui, A; Fushimi, H; Higashi, S; Iwase, K; Kawada, J; Matsuda, C; Nishikawa, K; Noguchi, Y; Nomura, M; Okumura, Y; Takagi, M; Tamagawa, H; Tanaka, Y; Yoshida, H | 1 |
| Baba, H; Fukuchi, M; Ishibashi, K; Ishida, H; Ishiguro, T; Kumagai, Y; Mochiki, E; Sobajima, J; Suzuki, O; Tsuji, Y | 1 |
| Gochi, A; Hasegawa, H; Imano, M; Matsuda, T; Morita, S; Murakami, N; Nagao, J; Naitoh, H; Nemoto, H; Nishikawa, K; Oka, M; Osanai, H; Saji, S; Sakamoto, J; Sakata, K; Shimizu, R; Suzuki, M; Tajiri, T; Takahashi, T; Tanaka, A; Yoshikawa, T; Yoshino, S | 1 |
| Suga, Y; Takehana, K | 1 |
1 review(s) available for lentinan and oxonic acid
| Article | Year |
|---|---|
[Anticancer immunotherapy with perorally effective lentinan].
Topics: Adjuvants, Immunologic; Administration, Oral; Antineoplastic Agents; beta-Glucans; Drug Combinations; Humans; Immunotherapy; Lentinan; Neoplasms; Oxonic Acid; Pyridines; Randomized Controlled Trials as Topic; Stomach Neoplasms; Tegafur | 2005 |
4 trial(s) available for lentinan and oxonic acid
| Article | Year |
|---|---|
[Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pilot Projects; Pyridines; Stomach Neoplasms; Survival Rate; Tegafur | 2003 |
[S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Quality of Life; Stomach Neoplasms; Survival Rate; Tegafur | 2006 |
[Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Immunotherapy; Lentinan; Neoplasm Staging; Oxonic Acid; Recurrence; Stomach Neoplasms; Survival Rate; Tegafur | 2008 |
Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Monocytes; Oxonic Acid; Quality of Life; Stomach Neoplasms; Tegafur | 2016 |
18 other study(ies) available for lentinan and oxonic acid
| Article | Year |
|---|---|
[A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Humans; Infusions, Intravenous; Krukenberg Tumor; Lentinan; Neoplasms, Multiple Primary; Ondansetron; Ovarian Neoplasms; Oxonic Acid; Pyridines; Stomach Neoplasms; Tegafur | 2003 |
[TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Topics: Adjuvants, Immunologic; Adult; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pyridines; Stomach Neoplasms; Tegafur | 2003 |
[TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Humans; Lentinan; Liver Neoplasms; Male; Middle Aged; Oxonic Acid; Pyridines; Quality of Life; Remission Induction; Stomach Neoplasms; Tegafur | 2004 |
Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Dendritic Cells; Drug Combinations; Fibrosarcoma; Immunotherapy, Adoptive; Lentinan; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Oxonic Acid; Pyridines; Rats; Rats, Inbred Strains; Spleen; Survival Rate; T-Lymphocytes, Cytotoxic; Tegafur | 2005 |
[Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Lentinan; Lung Neoplasms; Lymphatic Metastasis; Oxonic Acid; Recurrence; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed | 2008 |
[A case of the local advanced gastric cancer which became a resection possible in S-1/CDDP/lentinan neoadjuvant chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; Lentinan; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Splenectomy; Stomach Neoplasms; Tegafur | 2009 |
[Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Digestive System Neoplasms; Drug Combinations; Drug Therapy, Combination; Female; Humans; Lentinan; Male; Middle Aged; Oxonic Acid; Pancreatic Neoplasms; Stomach Neoplasms; Tegafur | 2010 |
[A case of advanced gastric cancer with distant lymph node metastases in cervical, supraclavicular and superior mediastinum successfully treated with S-1/Cisplatin (CDDP)/Lentinan combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastroscopy; Head; Humans; Lentinan; Lymphatic Metastasis; Neck; Neoplasm Staging; Oxonic Acid; Positron-Emission Tomography; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2010 |
[A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Combined Modality Therapy; Drug Combinations; Gastrectomy; Humans; Lentinan; Lymphatic Metastasis; Male; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2010 |
[A case of advanced gastric cancer responding to S-1/paclitaxel/lentinan as neoadjuvant chemoimmunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lentinan; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2010 |
Effects of lentinan alone and in combination with fluoropyrimidine anticancer agent on growth of human oral squamous cell carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Combinations; Female; Fluorouracil; Humans; Lentinan; Mice; Mice, Nude; Mouth Neoplasms; Oxonic Acid; Tegafur; Xenograft Model Antitumor Assays | 2010 |
[Combination chemotherapy of S-1/low-dose CDDP/lentinan for advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2011 |
[A case study of advanced gastric cancer patient treated with S-1+paclitaxel/lentinan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Gastrectomy; Humans; Lentinan; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Remission Induction; Stomach Neoplasms; Tegafur | 2012 |
The effect of lentinan combination therapy for unresectable advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Lentinan; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Retrospective Studies; Stomach Neoplasms; Tegafur | 2012 |
[A case of combined resection of multiple adjacent organs in a patient with locally advanced residual gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; Lentinan; Male; Neoplasm Invasiveness; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Tegafur; Treatment Outcome | 2013 |
[A case of advanced gastric cancer with para-aortic lymph node metastasis successfully treated with preoperative S-1/Lentinan chemotherapy followed by curative gastrectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Drug Combinations; Gastrectomy; Humans; Lentinan; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Tegafur | 2013 |
[Evaluation of immunity in elderly patients with unresectable gastric cancer receiving S-1/Lentinan combination chemotherapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Complement C3; Dinoprostone; Drug Combinations; Female; Humans; Lentinan; Male; Oxonic Acid; Prognosis; Stomach Neoplasms; T-Lymphocytes, Regulatory; Tegafur | 2014 |
Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration.
Topics: Administration, Intravenous; Animals; CD11b Antigen; Cell Line, Tumor; Colonic Neoplasms; Drug Combinations; Extracellular Vesicles; Humans; Ileum; Lentinan; Membrane Proteins; Mice; Mice, Inbred BALB C; Models, Animal; Oxonic Acid; Tegafur | 2017 |